Biogen Inc/ US09062X1037 /
| 07.11.2024 18:47:59 | Diff. +0,4468 | Volumen | Geld18:48:23 | Brief18:48:23 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 174,8468USD | +0,26% | 353.647 Umsatz: 39,67 Mio. |
174,7500Geld Vol: 800 | 174,8900Brief Vol: 800 | 25,46 Mrd.USD | - | 21,79 |
Aktiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 2.501,8000 | 3.182,4000 | 3.601,2000 | 3.247,3000 | 3.411,5000 | ||||||
| Immaterielle Vermögensgegenstände | 3.808,3000 | 3.879,6000 | 3.120 | 3.527,4000 | 3.084,3000 | ||||||
| Finanzanlagen | 2.829,4000 | 3.057,3000 | 1.375,9000 | 1.408,1000 | 772,1000 | ||||||
| Anlagevermögen | 14.144,6000 | 15.779,3000 | 17.648 | 18.852,5000 | 17.731,8000 | ||||||
| Vorräte | 1.001,6000 | 902,7000 | 929,9000 | 804,2000 | 1.068,6000 | ||||||
| Forderungen | 1.441,6000 | 1.787 | 1.958,5000 | 1.880,5000 | 1.913,8000 | ||||||
| Liquide Mitteln | 2.326,5000 | 1.573,8000 | 1.224,6000 | 2.913,7000 | 1.331,2000 | ||||||
| Umlaufvermögen | 8.732,2000 | 7.873,3000 | 7.640,9000 | 8.381,8000 | 6.887,1000 | ||||||
| Aktiva, gesamt | 22.876,8000 | 23.652,6000 | 25.288,9000 | 27.234,3000 | 24.618,9000 | ||||||
Passiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 279,8000 | 395,5000 | 370,5000 | 530,8000 | 454,9000 | ||||||
| Langfristige Schulden | 6.512,7000 | 5.935 | 5.936,5000 | 4.459 | 7.426,2000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 6.512,7000 | 5.935 | 5.936,5000 | 4.459 | 7.426,2000 | ||||||
| Rückstellungen | 325 | 190,8000 | 1.699,7000 | 2.882,2000 | 1.174,8000 | ||||||
| Verbindlichkeiten | 10.748,2000 | 11.054,5000 | 12.257,3000 | 13.895,2000 | 13.932,8000 | ||||||
| Gezeichnetes Kapital | ,1000 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
| Eigenkapital | 12.128,6000 | 12.598,1000 | 13.031,6000 | 13.339,1000 | 10.686,1000 | ||||||
| Minderheitenanteile | -11,5000 | -14,7000 | -8 | -4,1000 | -14,2000 | ||||||
| Passiva, gesamt | 22.876,8000 | 23.652,6000 | 25.288,9000 | 27.234,3000 | 24.618,9000 | ||||||
Gewinn- und Verlustrechnung
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 11.448,8000 | 12.273,9000 | 13.452,9000 | 14.377,9000 | 13.444,6000 | ||||||
| Abschreibungen (Gesamt) | 682,7000 | 1.081 | 1.016,6000 | 680,6000 | 457,2000 | ||||||
| Betriebsergebnis | 5.150,4000 | 5.344,2000 | 5.888,6000 | 7.042,6000 | 4.550,1000 | ||||||
| Zinsergebnis | -196,6000 | -172,3000 | -88,1000 | -67,4000 | -180,5000 | ||||||
| Ergebnis vor Steuern | 4.933 | 5.128,8000 | 5.899,6000 | 7.125,9000 | 5.047,5000 | ||||||
| Ertragsteuern | 1.237,3000 | 2.458,7000 | 1.425,6000 | 1.158 | 992,3000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -7,1000 | 131 | 43,3000 | 0.0000 | 59,9000 | ||||||
| Konzernjahresüberschuss | 3.702,8000 | 2.539,1000 | 4.430,7000 | 5.888,5000 | 4.000,6000 | ||||||
Pro Aktie
Cash Flow
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 4.522,4000 | 4.551 | 6.187,7000 | 7.078,6000 | 4.229,8000 | ||||||
| Cash Flow aus Investitionstätigkeit | -2.484,8000 | -2.963,1000 | -2.046,3000 | 470,5000 | -608,6000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -987,8000 | -2.380 | -4.472 | -5.860,4000 | -5.272,7000 | ||||||
| Veränderung der liquiden Mittel | 1.049,8000 | -792,1000 | -330,6000 | 1.688,7000 | -1.651,5000 | ||||||
| Anzahl der Mitarbeiter | 7.400 | 7.300 | 7.800 | 7.400 | 9.100 | ||||||
